Literature DB >> 20230883

Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.

Hong Yuan1, Wei Zhang, Yong-Zhong Du, Fu-Qiang Hu.   

Abstract

In this study, the lipid nanoparticles with excellent cellular uptake capacity were utilized to prepare lipid nanoparticles/protamine/DNA ternary nanoparticles for gene delivery. Anionic lipid nanoparticles consisting of monostearin (MS) and different content of oleic acid (OA) were prepared. The lipid nanoparticles had an average size ranging from 23.6 to 71.3 nm and a zeta potential about -30 mV. The protamine/DNA complex was prepared by mixing the DNA and protamine solution with 1:2 mass ratio. The average size of protamine/DNA complex was 128.5 nm and with 19.4 mV zeta potential. Lipid nanoparticles/protamine/DNA ternary nanoparticles were then prepared by combining the protamine/DNA binary complex with lipid nanoparticles. The ternary nanoparticles had an average size ranging from 192.7 to 260.6 nm and were negatively charged. Gene transfection efficiency was improved by increasing OA content in lipid nanoparticles. Results of cellular uptake showed that the uptake ability of lipid nanoparticles was enhanced by increasing the OA content. Lipid nanoparticles with 20 wt% OA/protamine/DNA ternary nanoparticles (w/w/w, 65:6:3) showed the best and the most durable gene transfection even in the presence of serum. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230883     DOI: 10.1016/j.ijpharm.2010.03.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

Review 2.  Oligonucleotide-based theranostic nanoparticles in cancer therapy.

Authors:  Reza Shahbazi; Bulent Ozpolat; Kezban Ulubayram
Journal:  Nanomedicine (Lond)       Date:  2016-04-22       Impact factor: 5.307

3.  pH-responsive biodegradable assemblies containing tunable phenyl-substituted vinyl ethers for use as efficient gene delivery vehicles.

Authors:  Hee-Kwon Kim; David H Thompson; Ho Seong Jang; Yong Jin Chung; Jeroen Van den Bossche
Journal:  ACS Appl Mater Interfaces       Date:  2013-06-17       Impact factor: 9.229

4.  Influence of cationic lipid concentration on properties of lipid-polymer hybrid nanospheres for gene delivery.

Authors:  Rajendran J C Bose; Yoshie Arai; Jong Chan Ahn; Hansoo Park; Soo-Hong Lee
Journal:  Int J Nanomedicine       Date:  2015-09-02

5.  Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.

Authors:  Sai-Nan He; Yun-Long Li; Jing-Jing Yan; Wei Zhang; Yong-Zhong Du; He-Yong Yu; Fu-Qiang Hu; Hong Yuan
Journal:  Int J Nanomedicine       Date:  2013-08-07

6.  Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles.

Authors:  Carine Dal Pizzol; Fabíola Branco Filippin-Monteiro; Jelver Alexander Sierra Restrepo; Frederico Pittella; Adny Henrique Silva; Paula Alves de Souza; Angela Machado de Campos; Tânia Beatriz Creczynski-Pasa
Journal:  Int J Environ Res Public Health       Date:  2014-08-20       Impact factor: 3.390

7.  Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.

Authors:  Pei Gao; Xiangyu Zhang; Hongzhi Wang; Qinghong Zhang; He Li; Yaogang Li; Yourong Duan
Journal:  Oncotarget       Date:  2016-01-19

8.  Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles.

Authors:  Noha Attia; Mohamed Mashal; Cristina Soto-Sánchez; Gema Martínez-Navarrete; Eduardo Fernández; Santiago Grijalvo; Ramón Eritja; Gustavo Puras; Jose Luis Pedraz
Journal:  Drug Des Devel Ther       Date:  2018-11-16       Impact factor: 4.162

Review 9.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

10.  Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics.

Authors:  Surasa Nagachinta; Belen Lopez Bouzo; Abi Judit Vazquez-Rios; Rafael Lopez; Maria de la Fuente
Journal:  Pharmaceutics       Date:  2020-02-22       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.